Avantor, Inc. (AVTR): Price and Financial Metrics

Avantor, Inc. (AVTR): $33.42

-0.05 (-0.15%)

POWR Rating

Component Grades













Add AVTR to Watchlist
Sign Up

Industry: Consumer Goods


of 71

in industry


  • Growth is the dimension where AVTR ranks best; there it ranks ahead of 98.18% of US stocks.
  • The strongest trend for AVTR is in Growth, which has been heading up over the past 31 weeks.
  • AVTR's current lowest rank is in the Value metric (where it is better than 52.8% of US stocks).

AVTR Stock Summary

  • Avantor Inc's market capitalization of $18,552,745,167 is ahead of 87.45% of US-listed equities.
  • Avantor Inc's stock had its IPO on May 17, 2019, making it an older stock than just 4.01% of US equities in our set.
  • AVTR's current price/earnings ratio is 109.78, which is higher than 92.41% of US stocks with positive earnings.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Avantor Inc are WLK, FUL, ATR, UHT, and NI.
  • Visit AVTR's SEC page to see the company's official filings. To visit the company's web site, go to www.avantorsciences.com.

AVTR Valuation Summary

AVTR's price/sales ratio is 2.8; this is 55.56% higher than that of the median Basic Materials stock.

Stock Date P/S P/B P/E EV/EBIT
AVTR 2021-05-12 2.6 6.2 103.6 46.4
AVTR 2020-07-15 1.8 4.5 -48.8 31.1
AVTR 2020-04-06 1.2 3.1 -22.4 25.9
AVTR 2020-02-11 1.7 4.2 -27.9 36.4
AVTR 2019-12-27 1.8 4.4 -29.2 37.5
AVTR 2019-06-28 1.7 -3.2 -28.2 40.7

AVTR Stock Price Chart Interactive Chart >

Price chart for AVTR

AVTR Price/Volume Stats

Current price $33.42 52-week high $33.99
Prev. close $33.47 52-week low $16.37
Day low $32.57 Volume 4,097,400
Day high $33.52 Avg. volume 4,289,046
50-day MA $31.68 Dividend yield N/A
200-day MA $27.73 Market Cap 19.46B

Avantor, Inc. (AVTR) Company Bio

Avantor, Inc. is a global provider of mission critical products and services. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables includes chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits. Equipment and instrumentation includes filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets and critical environment supplies. Services and specialty procurement include onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services.

AVTR Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$33.42$370.98 1090%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Avantor Inc. To summarize, we found that Avantor Inc ranked in the 90th percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 1096.17%. The most interesting components of our discounted cash flow analysis for Avantor Inc ended up being:

  • Its compound free cash flow growth rate, as measured over the past 1.99 years, is 1.14% -- higher than 91.55% of stocks in our DCF forecasting set.
  • The company has produced more trailing twelve month cash flow than 75.6% of its sector Basic Materials.
  • Avantor Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than only 0% of US stocks with positive free cash flow.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

Want more companies with a valuation profile/forecast similar to that of Avantor Inc? See SID, RFP, BCC, PQG, and CMC.

AVTR Latest News Stream

Event/Time News Detail
Loading, please wait...

AVTR Latest Social Stream

Loading social stream, please wait...

View Full AVTR Social Stream

Latest AVTR News From Around the Web

Below are the latest news stories about Avantor Inc that investors may wish to consider to help them evaluate AVTR as an investment opportunity.

Avantor® Completes Acquisition of Ritter GmbH and its Affiliates

RADNOR, Pa., June 10, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced today it has completed its previously announced

PR Newswire | June 10, 2021

How Covid Vaccines Could Push IBD Stock Of The Day Avantor Even Higher

Avantor is the IBD Stock Of The Day as shares shake off short-term resistance. Avantor stock is now eyeing a fresh breakout.

Investor''s Business Daily | June 10, 2021

Dow Jones Rally Led by Merck, Walgreens; Adobe Jumps Ahead Of Earnings, Avantor Gives Buy Signal

The Dow Jones and other major stock indexes recovered in afternoon trading after a morning swoon. Top gainers in the Dow included Walgreens and Merck.

Yahoo | June 10, 2021

Avantor Closes In On Buy Point

Avantor (AVTR, daily/weekly) flashed an early entry as it forms a flat base with a 34.09 buy point.

Yahoo | June 10, 2021

Tissue Processing Systems Market With Leading Players like MiltenyiBiotec, BioGenex, Leica Biosystems Nussloch GmbH (Danaher), Avantor, THERMO FISHER SCIENTIFIC, Siemens AG, F. HOFFMANN-LA ROCHE LTD., Agilent Technologies, Milestone Medical Sakura Finetek

An off-the-shelf report on Tissue Processing Systems Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market such

OpenPR | June 4, 2021

Read More 'AVTR' Stories Here

AVTR Price Returns

1-mo 5.73%
3-mo 14.92%
6-mo 21.79%
1-year 96.82%
3-year N/A
5-year N/A
YTD 18.72%
2020 55.10%
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8009 seconds.